Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

NCT07113132 is registered in ClinicalTrials.gov with Safaa Ali as lead sponsor.

NCT NCT07113132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07113132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
Lead sponsor
Safaa Ali
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
July 1, 2027
Enrollment
84 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia all, chronic lymphocytic leukemia (cll)